NEW

GE HealthCare Preps for SIR 2024

GE HealthCare will showcase its latest technologies in image guiding solutions, surgery, ultrasound and CT-navigation at the upcoming 2024 Society of Interventional Radiology (SIR) Annual Scientific Meeting taking place March 23-28 in Salt Lake City, Utah. The...

Samsung Accepts Healthcare Innovator Award

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award

AHRA Co-Founder Passes Away

On March 2, 2024, Louise Broadley passed away at 101 years old. AHRA shared the news via an email and website post that reads, “She was a noble woman, who not only achieved many milestones within the imaging profession, but likewise paved the way for aspiring leaders...

Artificial Intelligence Paper Outlines FDA’s Approach to Protect Public Health and Promote Ethical Innovation

Today, the U.S. Food and Drug Administration (FDA) released its “Artificial Intelligence and Medical Products: How CBER, CDER, CDRH, and OCP are Working Together,” which outlines how FDA’s medical product centers are working together to protect public health while...

Samsung Receives FDA Clearance for Premium Ultrasound System RS85

NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., announced that the Samsung RS85 ultrasound system has received FDA 510(k) clearance. The RS85 is the latest expansion of Samsung’s revolutionary ultrasound portfolio.

“We are pleased to launch the RS85, a new premium general imaging ultrasound system with superior image quality and usability based on Samsung’s advanced ultrasound and radiology technologies,” said Philip Sullivan, President and CEO of NeuroLogica. “The RS85 embodies Samsung’s commitment to providing leading technologies to healthcare providers by combining our key values of access, accuracy and efficiency.”

The release of the RS85 is the latest demonstration of Samsung’s ultrasound. It features an array of improvements, including:

  • MV-Flow: Allows for visualization of slow-flow micro vascularized structures, which can be difficult to assess with conventional power Doppler ultrasound. It also provides clinicians an additional way to check lesions for indications of cancer or inflammation.
  • S-Shearwave Imaging: Provides new indicators for clinical diagnosis by quantifying the elasticity of tissue or lesions via shearwave elastography, which may help increase the accuracy of diagnosis for breast and liver diseases.
  • CEUS+: Diagnoses and characterizes lesions in the liver using a contrast agent in adult and pediatric populations.
  • S-Fusion: Enables simultaneous localization of a lesion using real-time ultrasound in conjunction with other volumetric imaging modalities such as an MRI or a CT, while expanding its capabilities to the prostate gland for precise, targeted biopsy guidance.

The RS85 was also developed to help decrease user-fatigue and repetitive motions with an enhanced monitor arm and increased range of motion and tilt. These improvements allow the user to position the monitor for optimal viewing and control. Additionally, multi-step actions have been combined into a single step to help reduce keystrokes and repetitive user interface interactions.

“Samsung has built innovative and cutting-edge diagnostic ultrasound products for more than 30 years,” said David Legg, Vice President of Sales at NeuroLogica. “We are so confident that our RS85 ultrasound system will perform reliably and be the system that you can depend on for years to come, that we are proud to offer a 5-year warranty standard, at no additional cost.”

 

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

Open